Navigation Links
Abbott Nutrition Announces Voluntary Recall of ZonePerfect(R) Chocolate Peanut Butter Bars, ZonePerfect(R) Peanut Toffee Bars and NutriPals(TM) Peanut Butter Chocolate Bars in U.S., Mexico, New Zealand and Singapore
Date:1/19/2009

COLUMBUS, Ohio, Jan. 19 /PRNewswire-FirstCall/ -- Abbott Nutrition today announced that it is initiating a precautionary, voluntary recall of ZonePerfect(R) Chocolate Peanut Butter bars, ZonePerfect(R) Peanut Toffee bars and NutriPals(TM) Peanut Butter Chocolate bars in response to the widening recall involving peanut butter and peanut paste ingredients manufactured by Peanut Corporation of America (PCA). PCA was one of the peanut ingredient suppliers to the company.

The specified Abbott Nutrition items, sold in the U.S. and internationally (Mexico, New Zealand and Singapore) in various packages and quantities, have not been linked to a nationwide salmonella outbreak and there have been no reported cases of the salmonella illness associated with ZonePerfect or NutriPals products. Abbott Nutrition tests every lot of finished ZonePerfect and NutriPals bars for salmonella and no salmonella contamination has been detected. This voluntary recall does not apply to Abbott Nutrition products sold in Canada.

Abbott Nutrition's action to issue a voluntary recall was supported by the U.S. Food & Drug Administration's advisement to manufacturers of an ongoing outbreak of salmonella involving peanut butter and peanut paste supplied by PCA. No other Abbott Nutrition products have been impacted by the PCA recall.

As part of its priority to ensure the safety and quality of all of its products, Abbott is issuing the voluntary recall. Abbott is working with retail partners to remove the specified products from retail store shelves and encouraging customers and consumers to verify if they have the specified products.

Consumers who have purchased the recalled products are urged to destroy the product. U.S. consumers with questions or who would like a refund may contact Abbott Nutrition Consumer Relations at (800) 986-8884, Monday through Friday, between the hours of 8:30 a.m. and 5:00 p.m. Eastern Time. Consumers with questions or concerns about their health should contact their doctor.

    Products impacted by the voluntary withdrawal are as follows:

    * ZonePerfect Chocolate Peanut Butter bars, all sizes and quantities
    * ZonePerfect Peanut Toffee bars, all sizes and quantities
    * NutriPals Peanut Butter Chocolate nutrition bars, all sizes and
      quantities


    For images of these products, please visit the following link:

   http://abbottnutrition.com/pdf/peanut.pdf

Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis. For more information on Salmonella, please visit the Centers for Disease Control and Prevention's Website at http://www.cdc.gov.


'/>"/>
SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
Breaking Medicine Technology: